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Neuroinflammation results from a cellular 
cascade largely orchestrated by resident and 
infiltrating immune cells. Microglia, the resident 
immune cells of the central nervous system 
(CNS), function as sentinels in the normal 
tissue but can exacerbate pathology when 
activated by injury or disease. Injecting sub-
lethal doses of lipopolysaccharide (LPS), 
activates microglia but without causing 
damage. This “preconditioning” can be 
neuroprotective in the brain; however, it is not 
known if spinal cord microglia also  
can be preconditioned with LPS.  
 
 
Systemic LPS activates spinal 
cord microglia  2"
3"Primed microglia interact uniquely with spinal cord anatomy 
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Activated microglia do not induce 
neuropathology 5"
Primed microglia express elevated 
levels of inflammatory markers 
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LPS injection paradigm induces 
sickness behavior in mice 1"
Iba-1 staining shows microglia association patterns. 
(a,d) LPS treated microglia exhibit increased 
activation at the dorsal horn. (b,e) Activated 
microglia associate more readily with the central 
canal ependymal cells. (c,f) Vessels in LPS treated 
animals often have microglia surrounding them.  
LPS-treated microglia express higher levels of 
inflammatory markers CD16/32 and iNOS than PBS 
controls. 
Tissue preparation: Animals perfused with 0.1M phosphate 
buffer saline (PBS) and 4% paraformaldehyde 
Immunohistochemistry: Primary antibodies used: rabbit 
anti-Iba-1 (1:1000), rat anti-CD16/32 (1:800), rat anti-CD11b 
(1:1000), rabbit anti-Gal3 (1:4000), mouse anti-iNOS 
(1:1000), rabbit anti-caspase-3 (1:20,000), rat anti-
PECAM1(1:5000). 
Microscopy: Iba-1 density, anatomical analysis, and cresyl 
violet analysis visualize using light microscopy. All other 
stains visualized using epifluorescent microscopy. 
Analysis: Quantification was performed using batch analysis 
in MetaMorph. 
Hypothesis: 
Microglia activation marker Iba-1 was increased 
in LPS treated spinal cords 
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(a,b) Cresyl violet staining indicates normal neuron 
morphology. (c,d) PBS treated animals have fewer 
extraneuronal cells associating with neurons. (e,f) 
Ependymal cells were more rounded and numerous in 
LPS treated cords. 
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Day 1 Day 2 Day 3 Day 4 Day 5 
LPS Injection  
(1mg/kg i.p.) 
Sacrifice 
Neurons (stained green with NeuN) that contain 
apoptotic marker caspase-3 (red). Amount of 
caspase-3 was not different between groups 
indicating no changes in neuronal death 
LPS microglia (Iba-1, red) 
associate with vessels 
(PECAM-1, green) more 
extensively than PBS. 
Association delineated by 
arrows, non-associating 
microglia shown by arrowheads 
* 
More microglia are associated 
with blood vessels after LPS 
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Peripheral LPS 
will activate 
microglia 
 Microglia will exhibit an anti-
inflammatory 
phenotype 
Microglia will be 
preconditioned to be 
reparative. 
•  Peripheral LPS successfully activates spinal cord 
microglia without inducing neuropathology.  
•  Future studies will translate this phenomenon to study 
preconditioning in spinal cord inflammation (i.e. SCI). 
No neuropathology 
